18F-FAPI PET in Cancers of Unknown Primary Site

Starting soon

Conditions studied: Cancer of Unknown Primary Site

In brief

This study aims to evaluate the diagnostic efficacy, therapeutic assessment, prognostic analysis, and impact on clinical treatment decisions of 18F-FAPI PET/CT in patients with cancer of unknown primary.

Key facts

Study ID

NCT07372963

Run by

First Affiliated Hospital of Zhejiang University

People needed

120

Starts

2026-02-01

Expected to finish

2028-12-31

Last updated by the study team

2026-01-28

Who can join

Age: 20 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with clinical or imaging suspicion of cancer of unknown primary origin.
• Patients with 18F FAPI PET scans.

You may not qualify if…

• Concurrent presence of other active malignant tumors or a history of other malignant tumors within the past 5 years;
• Severe uncontrollable diseases or active infections;
• Ineligible participants for project informed consent.
• Pregnant and lactating women.

Where it is running

• The First Affiliated Hospital, Zhejiang University School of Medicine — Hangzhou, Zhejiang, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.